fda bpc 157 warning not approved What's behind the push to make peptide therapies more readily available : NPR bpc-157 fda warning 2025 september

The data is striking: in a Phase 2 trial published in the New England Journal of Medicine, the highest doses produced an average ~24% body-weight reduction at 11 months more than any currently approved weight-loss drug (American Diabetes Association)

Since MB is an FDA-approved medicine with a long history, the safety of MB usage has been thoroughly evaluated

Peripheral nerve Axonal regrowth runs on Schwann-cell and neurotrophic signaling, not blood supply nerve does not regrow because you fed it more blood

This bidirectional interaction enables restoration of normal NO balance critical for proper sphincter timing